Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET

Purpose The clinical utility of FDG-PET in diagnosing frontotemporal dementia (FTD) has been well demonstrated over the past decades. On the contrary, the diagnostic value of arterial spin labelling (ASL) MRI – a relatively new technique – in clinical diagnosis of FTD has yet to be confirmed. Using simultaneous PET/MRI, we evaluated the diagnostic performance of ASL in identifying pathological abnormalities in FTD (FTD) to determine whether ASL can provide similar diagnostic value as FDG-PET. Methods ASL and FDG-PET images were compared in 10 patients with FTD and 10 healthy older adults. Qualitative and quantitative measures of diagnostic equivalency were used to determine the diagnostic utility of ASL compared to FDG-PET. Sensitivity, specificity, and inter-rater reliability were calculated for each modality from scores of subjective visual ratings and from analysis of regional mean values in thirteen a priori regions of interest (ROI). To determine the extent of concordance between modalities in each patient, individual statistical maps generated from comparison of each patient to controls were compared between modalities using the Jaccard similarity index (JI). Results Visual assessments revealed lower sensitivity, specificity and inter-rater reliability for ASL (66.67%/62.12%/0.2) compared to FDG-PET (88.43%/90.91%/0.61). Across all regions, ASL performed lower than FDG-PET in discriminating patients from controls (areas under the receiver operating curve: ASL = 0.75 and FDG-PET = 0.87). In all patients, ASL identified patterns of reduced perfusion consistent with FTD, but areas of hypometabolism exceeded hypoperfused areas (group-mean JI = 0.30 ± 0.22). Conclusion This pilot study demonstrated that ASL can detect similar spatial patterns of abnormalities in individual FTD patients compared to FDG-PET, but its sensitivity and specificity for discriminant diagnosis of a patient from healthy individuals remained unmatched to FDG-PET. Further studies at the individual level are required to confirm the clinical role of ASL in FTD management.

[1]  Albert Gjedde,et al.  Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease , 2009, NeuroImage.

[2]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[3]  G. Zaharchuk,et al.  Arterial spin-label imaging in patients with normal bolus perfusion-weighted MR imaging findings: pilot identification of the borderzone sign. , 2009, Radiology.

[4]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[5]  Suvankar Pal,et al.  Systematic review of the diagnostic utility of SPECT imaging in dementia , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  Mayank A. Jog,et al.  Regional Correlation between Resting State FDG PET and pCASL Perfusion MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  H J Testa,et al.  Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  John A. Detre,et al.  Comparison of 2D and 3D single-shot ASL perfusion fMRI sequences , 2013, NeuroImage.

[9]  E. Finger,et al.  Association between Montreal Cognitive Assessment Sub-Item Scores and Corresponding Cognitive Test Performance in Patients with Frontotemporal Dementia and Related Disorders , 2017, Dementia and Geriatric Cognitive Disorders.

[10]  J. Trojanowski,et al.  Distinct cerebral perfusion patterns in FTLD and AD , 2010, Neurology.

[11]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[12]  G. Houston,et al.  Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia , 2014, Human brain mapping.

[13]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[14]  D. Feinberg,et al.  Single‐shot 3D imaging techniques improve arterial spin labeling perfusion measurements , 2005, Magnetic resonance in medicine.

[15]  Paul H. Garthwaite,et al.  Single-case research in neuropsychology: A comparison of five forms of t-test for comparing a case to controls , 2012, Cortex.

[16]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[17]  Norbert Schuff,et al.  Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.

[18]  D. Perani,et al.  Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series. , 2015, Journal of Alzheimer's Disease.

[19]  T D Miller,et al.  Accuracy of single-photon emission computed tomography myocardial perfusion imaging in patients with stents in native coronary arteries. , 1998, The American journal of cardiology.

[20]  N. Schuff,et al.  Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection , 2015, The Lancet Neurology.

[21]  Feng Xu,et al.  Estimation of labeling efficiency in pseudocontinuous arterial spin labeling , 2010, Magnetic resonance in medicine.

[22]  Wang Zhan,et al.  Joint Assessment of Structural, Perfusion, and Diffusion MRI in Alzheimer's Disease and Frontotemporal Dementia , 2011, International journal of Alzheimer's disease.

[23]  S. Holm,et al.  Region specific optimization of continuous linear attenuation coefficients based on UTE (RESOLUTE): application to PET/MR brain imaging , 2015, Physics in medicine and biology.

[24]  Kirsten M. Wilkins,et al.  Annals of General Psychiatry BioMed Central Review Frontotemporal Dementias , 2006 .

[25]  Udunna Anazodo,et al.  A hybrid strategy for correcting geometric distortion in echo-planar images. , 2014, Magnetic resonance imaging.

[26]  John Hobson,et al.  The Montreal Cognitive Assessment (MoCA). , 2015, Occupational medicine.

[27]  H. Matsuda,et al.  Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  John R. Hodges,et al.  Epidemiology of frontotemporal dementia , 2007 .

[29]  Karsten Mueller,et al.  Combined Evaluation of FDG-PET and MRI Improves Detection and Differentiation of Dementia , 2011, PloS one.

[30]  J. S. Lee,et al.  18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  A. Drzezga,et al.  Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study , 2007, Neurobiology of Aging.

[32]  Yi Wang,et al.  Multi-vendor reliability of arterial spin labeling perfusion MRI using a near-identical sequence: Implications for multi-center studies , 2015, NeuroImage.

[33]  Marion Smits,et al.  Early-stage differentiation between presenile Alzheimer’s disease and frontotemporal dementia using arterial spin labeling MRI , 2015, European Radiology.

[34]  Jyrki Lötjönen,et al.  Robust whole-brain segmentation: Application to traumatic brain injury , 2015, Medical Image Anal..

[35]  Christine Delmaire,et al.  Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG‐PET in Early‐Onset Alzheimer's Disease , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[36]  A. Laird,et al.  Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses – The case of behavioral variant frontotemporal dementia , 2014, Cortex.

[37]  E. Achten,et al.  A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice , 2015, Neuroradiology.

[38]  Mike P. Wattjes,et al.  Cerebral perfusion and glucose metabolism in Alzheimer’s disease and frontotemporal dementia: two sides of the same coin? , 2015, European Radiology.

[39]  K. Ishii,et al.  Cerebral glucose metabolism in patients with frontotemporal dementia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  N. Schuff,et al.  Diagnostic utility of ASL‐MRI and FDG‐PET in the behavioral variant of FTD and AD , 2016, Annals of clinical and translational neurology.

[41]  M. Mendez,et al.  Accuracy of the clinical evaluation for frontotemporal dementia. , 2007, Archives of neurology.

[42]  F. Barkhof,et al.  Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET , 2017, European Radiology.

[43]  N. Schuff,et al.  Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.

[44]  C. DeCarli,et al.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.

[45]  F. Prato,et al.  Feasibility of simultaneous whole-brain imaging on an integrated PET-MRI system using an enhanced 2-point Dixon attenuation correction method , 2015, Front. Neurosci..

[46]  Janet S. Reddin,et al.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.

[47]  Kristian Bredies,et al.  Spatio-temporal TGV denoising for ASL perfusion imaging , 2017, NeuroImage.

[48]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[49]  William J. Jagust,et al.  The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment : A Consensus Report , 2004 .

[50]  M. Vernooij,et al.  Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage dementia: Comparison of arterial spin labelling MRI and FDG PET-CT in suspected dementia. , 2017, Clinical imaging.

[51]  Matthias Günther,et al.  Correction for Susceptibility Distortions Increases the Performance of Arterial Spin Labeling in Patients with Cerebrovascular Disease , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[52]  Rebecca M. E. Steketee,et al.  Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI , 2016, European Radiology.

[53]  Robin B. Holmes,et al.  The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia , 2005, Nuclear medicine communications.

[54]  Albert Gjedde,et al.  Normalization in PET group comparison studies—The importance of a valid reference region , 2008, NeuroImage.

[55]  A. Catafau,et al.  Brain SPECT in clinical practice. Part I: perfusion. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[56]  Peiying Liu,et al.  Comparison of relative cerebral blood flow maps using pseudo‐continuous arterial spin labeling and single photon emission computed tomography , 2012, NMR in biomedicine.

[57]  Maja A. A. Binnewijzend,et al.  Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. , 2013, Radiology.

[58]  B. Miller,et al.  Classification of primary progressive aphasia and its variants , 2011, Neurology.